Login Register Cart 0
Central Nervous System Agents in Medicinal Chemistry

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

An Updated Review of Potential Drug Targets for Japanese Encephalitis

Author(s): Roshini Singh, Sayak Sanyal, Nikita Basant and Somali Sanyal*

Volume 26, Issue 1, 2026

Published on: 16 April, 2025

Page: [46 - 62] Pages: 17

DOI: 10.2174/0118715249353956250326164211

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Japanese encephalitis virus (JEV), first identified in 1935, continues to be a major threat to human health, especially in the Asia-Pacific region, where it remains prevalent. JEV, a neurotropic flavivirus, spreads through Culex tritaeniorhynchus mosquito bites and causes severe brain infections with high morbidity and mortality rates. Despite the availability of vaccines, no licensed anti-JEV drugs exist. This review provides a comprehensive overview of the epidemiology, structural and nonstructural proteins, and pathogenesis of JEV and explores potential drug targets. This study highlights both conventional and nonconventional drug targets, with a focus on nonstructural JEV proteins, which may hold promise for therapeutic development. This review also discusses drug targets shared by JEV and other flaviviruses, such as dengue, Zika, and West Nile virus, which reveal common pathways for viral entry and replication, along with distinct mechanisms specific to JEV. Key receptor interactions, including DC-SIGN, TAM receptor, sialic acid, LDLR, and CLEC5A interactions, are involved in JEV transmission and immune evasion. Additionally, the NMDA receptor has been identified as a critical player in JEV pathogenesis, suggesting new opportunities for neuroprotective therapies. A major obstacle in JEV drug development is the blood-brain barrier (BBB), which hinders the delivery of therapeutic agents to the central nervous system (CNS). Recent research has emphasized the need for innovative drug delivery systems that can cross the BBB, reducing viral replication and neural damage. While clinical trials with traditional antivirals have yielded mixed results, live attenuated and inactivated vaccines have shown promise in preventing JEV infection. Additionally, nucleic acid-based therapies, including microRNAs and short hairpin RNAs (shRNAs), are emerging as potential treatments, with nanoparticle-based delivery systems offering solutions to overcome BBB challenges. This review underscores the need for an integrated approach, including improved vaccines, targeted drug delivery strategies, and novel therapeutics, to effectively combat JEV infections on a global scale.

Keywords: Japanese encephalitis virus (JEV), Culex tritaeniorhynchus, flavivirus, JEV drug targets, blood-brain barrier (BBB), nucleic acid-based therapies.

« Previous Next »

Graphical Abstract

Graphical abstract illustrating key findings of the study

[1]
McMinn, P.C. The molecular basis of virulence of the encephalitogenic flaviviruses. J. Gen. Virol., 1997, 78(11), 2711-2722.
[http://dx.doi.org/10.1099/0022-1317-78-11-2711] [PMID: 9367356]
[2]
Solomon, T.; Ni, H.; Beasley, D.W.C.; Ekkelenkamp, M.; Cardosa, M.J.; Barrett, A.D.T. Origin and evolution of Japanese encephalitis virus in Southeast Asia. J. Virol., 2003, 77(5), 3091-3098.
[http://dx.doi.org/10.1128/JVI.77.5.3091-3098.2003] [PMID: 12584335]
[3]
Faizah, A.N.; Kobayashi, D.; Amoa-Bosompem, M.; Higa, Y.; Tsuda, Y.; Itokawa, K.; Miura, K.; Hirayama, K.; Sawabe, K.; Isawa, H. Correction: Evaluating the competence of the primary vector, Culex tritaeniorhynchus, and the invasive mosquito species, Aedes japonicus japonicus, in transmitting three Japanese encephalitis virus genotypes. PLoS Negl. Trop. Dis., 2023, 17(1), e0011052.
[http://dx.doi.org/10.1371/journal.pntd.0011052] [PMID: 36634069]
[4]
Su, C.L.; Yang, C.F.; Teng, H.J.; Lu, L.C.; Lin, C.; Tsai, K.H.; Chen, Y.Y.; Chen, L.Y.; Chang, S.F.; Shu, P.Y. Molecular epidemiology of Japanese encephalitis virus in mosquitoes in Taiwan during 2005-2012. PLoS Negl. Trop. Dis., 2014, 8(10), e3122.
[http://dx.doi.org/10.1371/journal.pntd.0003122] [PMID: 25275652]
[5]
Buescher, E.L.; Scherer, W.F.; Rosenberg, M.Z.; Gresser, I.; Hardy, J.L.; Bullock, H.R. Ecologic studies of Japanese encephalitis virus in Japan. II. Mosquito infection. Am. J. Trop. Med. Hyg., 1959, 8(6), 651-664.
[http://dx.doi.org/10.4269/ajtmh.1959.8.651] [PMID: 13805722]
[6]
Weaver, S.C.; Barrett, A.D.T. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat. Rev. Microbiol., 2004, 2(10), 789-801.
[http://dx.doi.org/10.1038/nrmicro1006] [PMID: 15378043]
[7]
Mackenzie, J.S.; Williams, D.T.; van den Hurk, A.F.; Smith, D.W.; Currie, B.J. Japanese encephalitis virus: The emergence of genotype IV in Australia and its potential endemicity. Viruses, 2022, 14(11), 2480.
[http://dx.doi.org/10.3390/v14112480] [PMID: 36366578]
[8]
Billoir, F.; de Micco, P.; Tolou, H.; de Chesse, R.; de Lamballerie, X.; Gould, E.A. Phylogeny of the genus Flavivirus using complete coding sequences of arthropod-borne viruses and viruses with no known vector. J. Gen. Virol., 2000, 81(3), 781-790.
[http://dx.doi.org/10.1099/0022-1317-81-3-781] [PMID: 10675416]
[9]
Quan, T.M.; Thao, T.T.N.; Duy, N.M.; Nhat, T.M.; Clapham, H. Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015. eLife, 2020, 9, e51027.
[http://dx.doi.org/10.7554/eLife.51027] [PMID: 32450946]
[10]
Pearce, J.C.; Learoyd, T.P.; Langendorf, B.J.; Logan, J.G. Japanese encephalitis: The vectors, ecology and potential for expansion. J. Travel Med., 2018, 25(Suppl. 1), S16-S26.
[http://dx.doi.org/10.1093/jtm/tay009] [PMID: 29718435]
[11]
Campbell, G.; Hills, S.; Fischer, M.; Jacobson, J.; Hoke, C.; Hombach, J.; Marfin, A.; Solomon, T.; Tsai, T.; Tsui, V.; Ginsburg, A. Estimated global incidence of Japanese encephalitis. Bull. World Health Organ., 2011, 89(10), 766-774, 774A-774E.
[http://dx.doi.org/10.2471/BLT.10.085233] [PMID: 22084515]
[12]
Joe, S.; Salam, A.A.A.; Neogi, U.; N, N.B.; Mudgal, P.P. Antiviral drug research for Japanese encephalitis: An updated review. Pharmacol. Rep., 2022, 74(2), 273-296.
[http://dx.doi.org/10.1007/s43440-022-00355-2] [PMID: 35182390]
[13]
Solomon, T.; Dung, N.M.; Kneen, R.; Gainsborough, M.; Vaughn, D.W.; Khanh, V.T. Neurological aspects of tropical disease: Japanese encephalitis. J. Neurol. Neurosurg. Psychiatry, 2000, 68(4), 405-415.
[http://dx.doi.org/10.1136/jnnp.68.4.405] [PMID: 10727474]
[14]
Yun, S.I.; Lee, Y.M. Japanese encephalitis: The virus and vaccines. Hum. Vaccin. Immunother., 2014, 10(2), 263-279.
[http://dx.doi.org/10.4161/hv.26902] [PMID: 24161909]
[15]
Gubler, D.J.; Kuno, G.; Markoff, L. Flaviviruses. Fields Virology, 2007, 1, 1153-1253.
[16]
Tsai, T.F. New initiatives for the control of Japanese encephalitis by vaccination. Vaccine, 2000, 18(Suppl. 2), 1-25.
[http://dx.doi.org/10.1016/S0264-410X(00)00037-2] [PMID: 10821969]
[17]
Misra, U.K.; Kalita, J. Overview: Japanese encephalitis. Prog. Neurobiol., 2010, 91(2), 108-120.
[http://dx.doi.org/10.1016/j.pneurobio.2010.01.008] [PMID: 20132860]
[18]
Solomon, T.; Vaughn, D.W. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr. Top. Microbiol. Immunol., 2002, 267, 171-194.
[http://dx.doi.org/10.1007/978-3-642-59403-8_9] [PMID: 12082989]
[19]
Solomon, T.; Winter, P.M. Neurovirulence and host factors in flavivirus encephalitis — evidence from clinical epidemiology. Arch. Virol. Suppl., 2004, (18), 161-170.
[http://dx.doi.org/10.1007/978-3-7091-0572-6_14] [PMID: 15119771]
[20]
Monath, T.P. Japanese encephalitis vaccines: Current vaccines and future prospects. Curr. Top. Microbiol. Immunol., 2002, 267, 105-138.
[http://dx.doi.org/10.1007/978-3-642-59403-8_6] [PMID: 12082985]
[21]
Burke, D.S.; Leake, C.J. Japanese encephalitis. In: The Arboviruses: Epidemiology and Ecology; Monath, T.P., Ed.; CRC: Boca Raton, FL, 1988; pp. 63-92.
[22]
Vaughn, D.W.; Hoke, C.H., Jr The epidemiology of Japanese encephalitis: Prospects for prevention. Epidemiol. Rev., 1992, 14(1), 197-221.
[http://dx.doi.org/10.1093/oxfordjournals.epirev.a036087] [PMID: 1337744]
[23]
Japanese encephalitis vaccines. Wkly. Epidemiol. Rec., 2006, 81(35), 331-340.
[PMID: 16933380]
[24]
Longbottom, J.; Browne, A.J.; Pigott, D.M.; Sinka, M.E.; Golding, N.; Hay, S.I.; Moyes, C.L.; Shearer, F.M. Mapping the spatial distribution of the Japanese encephalitis vector, Culex tritaeniorhynchus Giles, 1901 (Diptera: Culicidae) within areas of Japanese encephalitis risk. Parasit. Vectors, 2017, 10(1), 148.
[http://dx.doi.org/10.1186/s13071-017-2086-8] [PMID: 28302156]
[25]
Tiwari, S.; Singh, R.K.; Tiwari, R.; Dhole, T.N. Japanese encephalitis: A review of the Indian perspective. Braz. J. Infect. Dis., 2012, 16(6), 564-573.
[http://dx.doi.org/10.1016/j.bjid.2012.10.004] [PMID: 23141974]
[26]
Liang, G.D.; Huanyu, W. Epidemiology of Japanese encephalitis: Past, present, and future prospects. Ther. Clin. Risk Manag., 2015, 435, 435.
[http://dx.doi.org/10.2147/TCRM.S51168]
[27]
Touch, S.; Hills, S.; Sokhal, B.; Samnang, C.; Sovann, L.; Khieu, V.; Soeung, S.C.; Toda, K.; Robinson, J.; Grundy, J. Epidemiology and burden of disease from Japanese encephalitis in Cambodia: Results from two years of sentinel surveillance. Trop. Med. Int. Health, 2009, 14(11), 1365-1373.
[http://dx.doi.org/10.1111/j.1365-3156.2009.02380.x] [PMID: 19747185]
[28]
Kulkarni, R.; Sapkal, G.N.; Kaushal, H.; Mourya, D.T. Japanese encephalitis: A brief review on Indian perspectives. Open Virol. J., 2018, 12(1), 121-130.
[http://dx.doi.org/10.2174/1874357901812010121] [PMID: 30288200]
[29]
Jay Prakash, P.; Kusum, V.; Vijeta, S. Japanese Encephalitis (JE): A curse for people living in Uttar Pradesh, India. J. Vaccines Immun., 2021, 036–040, 036-040.
[http://dx.doi.org/10.17352/jvi.000045]
[30]
Solomon, T. Control of Japanese encephalitis-within our grasp? N. Engl. J. Med., 2006, 355(9), 869-871.
[http://dx.doi.org/10.1056/NEJMp058263] [PMID: 16943399]
[31]
Walsh, M.G.; Pattanaik, A.; Vyas, N.; Saxena, D.; Webb, C.; Sawleshwarkar, S.; Mukhopadhyay, C. High-risk landscapes of Japanese encephalitis virus outbreaks in India converge on wetlands, rain-fed agriculture, wild Ardeidae, and domestic pigs and chickens. Int. J. Epidemiol., 2022, 51(5), 1408-1418.
[http://dx.doi.org/10.1093/ije/dyac050] [PMID: 35355081]
[32]
Singh, L.S.; Singh, H.L.; Thokchom, N.; Singh, R.K.M. A descriptive study on prevalence pattern of Japanese encephalitis in State of Manipur. Indian J. Med. Microbiol., 2019, 37(2), 235-240.
[http://dx.doi.org/10.4103/ijmm.IJMM_18_180] [PMID: 31745025]
[33]
Yun, S.I.; Kim, S.Y.; Choi, W.Y.; Nam, J.H.; Ju, Y.R.; Park, K.Y.; Cho, H.W.; Lee, Y.M. Molecular characterization of the full-length genome of the Japanese encephalitis viral strain K87P39. Virus Res., 2003, 96(1-2), 129-140.
[http://dx.doi.org/10.1016/S0168-1702(03)00181-3] [PMID: 12951273]
[34]
Pyke, A.T.; Williams, D.T.; Nisbet, D.J.; van den Hurk, A.F.; Taylor, C.T.; Johansen, C.A.; Macdonald, J.; Hall, R.A.; Simmons, R.J.; Mason, R.J.; Lee, J.M.; Ritchie, S.A.; Smith, G.A.; Mackenzie, J.S. The appearance of a second genotype of Japanese encephalitis virus in the Australasian region. Am. J. Trop. Med. Hyg., 2001, 65(6), 747-753.
[http://dx.doi.org/10.4269/ajtmh.2001.65.747] [PMID: 11791969]
[35]
Williams, D.T.; Wang, L.F.; Daniels, P.W.; Mackenzie, J.S. Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain. J. Gen. Virol., 2000, 81(10), 2471-2480.
[http://dx.doi.org/10.1099/0022-1317-81-10-2471] [PMID: 10993935]
[36]
Paranjpe, S.; Banerjee, K. Phylogenetic analysis of the envelope gene of Japanese encephalitis virus. Virus Res., 1996, 42(1-2), 107-117.
[http://dx.doi.org/10.1016/0168-1702(96)01306-8] [PMID: 8806178]
[37]
Schuh, A.J.; Li, L.; Tesh, R.B.; Innis, B.L.; Barrett, A.D.T. Genetic characterization of early isolates of Japanese encephalitis virus: Genotype II has been circulating since at least 1951. J. Gen. Virol., 2010, 91(1), 95-102.
[http://dx.doi.org/10.1099/vir.0.013631-0] [PMID: 19776238]
[38]
Chen, W.R.; Rico-Hesse, R.; Tesh, R.B. A new genotype of Japanese encephalitis virus from Indonesia. Am. J. Trop. Med. Hyg., 1992, 47(1), 61-69.
[http://dx.doi.org/10.4269/ajtmh.1992.47.61] [PMID: 1322071]
[39]
Mohammed, M.A.F.; Galbraith, S.E.; Radford, A.D.; Dove, W.; Takasaki, T.; Kurane, I.; Solomon, T. Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype. Infect. Genet. Evol., 2011, 11(5), 855-862.
[http://dx.doi.org/10.1016/j.meegid.2011.01.020] [PMID: 21352956]
[40]
Huong, V.T.Q.; Ha, D.Q.; Deubel, V. Genetic study of Japanese encephalitis viruses from Vietnam. Am. J. Trop. Med. Hyg., 1993, 49(5), 538-544.
[http://dx.doi.org/10.4269/ajtmh.1993.49.538] [PMID: 8250093]
[41]
Ishikawa, T.; Konishi, E. Japanese encephalitis: Epidemiology, prevention and current status of antiviral drug development. Expert Opin. Orphan Drugs, 2014, 2(9), 923-936.
[http://dx.doi.org/10.1517/21678707.2014.934222]
[42]
Scherer, W.F.; Buescher, E.L.; McClure, H.E. Ecologic studies of Japanese encephalitis virus in Japan. V. Avian factors. Am. J. Trop. Med. Hyg., 1959, 8(6), 689-697.
[http://dx.doi.org/10.4269/ajtmh.1959.8.689] [PMID: 14442651]
[43]
van den Hurk, A.F.; Ritchie, S.A.; Mackenzie, J.S. Ecology and geographical expansion of Japanese encephalitis virus. Annu. Rev. Entomol., 2009, 54(1), 17-35.
[http://dx.doi.org/10.1146/annurev.ento.54.110807.090510] [PMID: 19067628]
[44]
Le Flohic, G.; Porphyre, V.; Barbazan, P.; Gonzalez, J.P. Review of climate, landscape, and viral genetics as drivers of the Japanese encephalitis virus ecology. PLoS Negl. Trop. Dis., 2013, 7(9), e2208.
[http://dx.doi.org/10.1371/journal.pntd.0002208] [PMID: 24069463]
[45]
Surathin, S.; Surathin, K.; Shrestha, S.R.. Vectors of Japanese Encephalitis Virus (JEV): Species complexes of the vectors. Southeast Asian J. Trop. Med. Public Health, 1989, 611(2), 20.
[46]
Lindenbach, B.D.; Murray, C.; Thiel, H.J. Flaviviridae. In: Fields virology, 6th ed; Knipe, D.M.; Howley, P.M., Eds.; Lippincott William: Philadelphia, 2013; pp. 712-746.
[47]
Zhang, Y.; Corver, J.; Chipman, P.R.; Zhang, W.; Pletnev, S.V.; Sedlak, D.; Baker, T.S.; Strauss, J.H.; Kuhn, R.J.; Rossmann, M.G. Structures of immature flavivirus particles. EMBO J., 2003, 22(11), 2604-2613.
[http://dx.doi.org/10.1093/emboj/cdg270] [PMID: 12773377]
[48]
Erlanger, T.E.; Weiss, S.; Keiser, J.; Utzinger, J.; Wiedenmayer, K. Past, present, and future of Japanese encephalitis. Emerg. Infect. Dis., 2009, 15(1), 1-7.
[http://dx.doi.org/10.3201/eid1501.080311] [PMID: 19116041]
[49]
Ma, L.; Jones, C.T.; Groesch, T.D.; Kuhn, R.J.; Post, C.B. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl. Acad. Sci. USA, 2004, 101(10), 3414-3419.
[http://dx.doi.org/10.1073/pnas.0305892101] [PMID: 14993605]
[50]
Tan, T.Y.; Fibriansah, G.; Kostyuchenko, V.A.; Ng, T.S.; Lim, X.X.; Zhang, S.; Lim, X.N.; Wang, J.; Shi, J.; Morais, M.C.; Corti, D.; Lok, S.M. Capsid protein structure in Zika virus reveals the flavivirus assembly process. Nat. Commun., 2020, 11(1), 895.
[http://dx.doi.org/10.1038/s41467-020-14647-9] [PMID: 32060358]
[51]
Hu, T.; Wu, Z.; Wu, S.; Chen, S.; Cheng, A. The key amino acids of E protein involved in early flavivirus infection: Viral entry. Virol. J., 2021, 18(1), 136.
[http://dx.doi.org/10.1186/s12985-021-01611-2] [PMID: 34217298]
[52]
Lorenz, I.C.; Allison, S.L.; Heinz, F.X.; Helenius, A. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J. Virol., 2002, 76(11), 5480-5491.
[http://dx.doi.org/10.1128/JVI.76.11.5480-5491.2002] [PMID: 11991976]
[53]
Poonsiri, T.; Wright, G.S.A.; Solomon, T.; Antonyuk, S.V. Crystal structure of the Japanese Encephalitis virus capsid protein. Viruses, 2019, 11(7), 623.
[http://dx.doi.org/10.3390/v11070623] [PMID: 31284608]
[54]
Lindenbach, B.D.; Rice, C.M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol., 1997, 71(12), 9608-9617.
[http://dx.doi.org/10.1128/jvi.71.12.9608-9617.1997] [PMID: 9371625]
[55]
Leung, J.Y.; Pijlman, G.P.; Kondratieva, N.; Hyde, J.; Mackenzie, J.M.; Khromykh, A.A. Role of nonstructural protein NS2A in flavivirus assembly. J. Virol., 2008, 82(10), 4731-4741.
[http://dx.doi.org/10.1128/JVI.00002-08] [PMID: 18337583]
[56]
Sampath, A.; Padmanabhan, R. Molecular targets for flavivirus drug discovery. Antiviral Res., 2009, 81(1), 6-15.
[http://dx.doi.org/10.1016/j.antiviral.2008.08.004] [PMID: 18796313]
[57]
Egloff, M.P.; Benarroch, D.; Selisko, B.; Romette, J.L.; Canard, B. An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: Crystal structure and functional characterization. EMBO J., 2002, 21(11), 2757-2768.
[http://dx.doi.org/10.1093/emboj/21.11.2757] [PMID: 12032088]
[58]
Falgout, B.; Pethel, M.; Zhang, Y.M.; Lai, C.J. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol., 1991, 65(5), 2467-2475.
[http://dx.doi.org/10.1128/jvi.65.5.2467-2475.1991] [PMID: 2016768]
[59]
van den Elsen, K.; Chew, B.L.A.; Ho, J.S.; Luo, D. Flavivirus nonstructural proteins and replication complexes as antiviral drug targets. Curr. Opin. Virol., 2023, 59, 101305.
[http://dx.doi.org/10.1016/j.coviro.2023.101305] [PMID: 36870091]
[60]
Klaitong, P.; Smith, D.R. Roles of non-structural protein 4A in flavivirus infection. Viruses, 2021, 13(10), 2077.
[http://dx.doi.org/10.3390/v13102077] [PMID: 34696510]
[61]
Xie, X.; Zou, J.; Wang, Q.Y.; Shi, P.Y. Targeting dengue virus NS4B protein for drug discovery. Antiviral Res., 2015, 118, 39-45.
[http://dx.doi.org/10.1016/j.antiviral.2015.03.007] [PMID: 25796970]
[62]
Liu, L.; Dong, H.; Chen, H.; Zhang, J.; Ling, H.; Li, Z.; Shi, P.Y.; Li, H. Flavivirus RNA cap methyltransferase: Structure, function, and inhibition. Front. Biol. (Beijing), 2010, 5(4), 286-303.
[http://dx.doi.org/10.1007/s11515-010-0660-y] [PMID: 21927615]
[63]
Godoy, A.S.; Lima, G.M.A.; Oliveira, K.I.Z.; Torres, N.U.; Maluf, F.V.; Guido, R.V.C.; Oliva, G. Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase. Nat. Commun., 2017, 8(1), 14764.
[http://dx.doi.org/10.1038/ncomms14764] [PMID: 28345596]
[64]
Qian, X.; Qi, Z. Mosquito-borne flaviviruses and current therapeutic advances. Viruses, 2022, 14(6), 1226.
[http://dx.doi.org/10.3390/v14061226] [PMID: 35746697]
[65]
Wang, B.; Thurmond, S.; Zhou, K.; Sánchez-Aparicio, M.T.; Fang, J.; Lu, J.; Gao, L.; Ren, W.; Cui, Y.; Veit, E.C.; Hong, H.; Evans, M.J.; O’Leary, S.E.; García-Sastre, A.; Zhou, Z.H.; Hai, R.; Song, J. Structural basis for STAT2 suppression by flavivirus NS5. Nat. Struct. Mol. Biol., 2020, 27(10), 875-885.
[http://dx.doi.org/10.1038/s41594-020-0472-y] [PMID: 32778820]
[66]
Barzon, L.; Palù, G. Recent developments in vaccines and biological therapies against Japanese encephalitis virus. Expert Opin. Biol. Ther., 2018, 18(8), 851-864.
[http://dx.doi.org/10.1080/14712598.2018.1499721] [PMID: 29991325]
[67]
Turtle, L.; Solomon, T. Japanese encephalitis — the prospects for new treatments. Nat. Rev. Neurol., 2018, 14(5), 298-313.
[http://dx.doi.org/10.1038/nrneurol.2018.30] [PMID: 29697099]
[68]
Yun, S.I.; Lee, Y.M. Early events in Japanese Encephalitis virus infection: Viral entry. Pathogens, 2018, 7(3), 68.
[http://dx.doi.org/10.3390/pathogens7030068] [PMID: 30104482]
[69]
Konishi, E.; Mason, P.W. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol., 1993, 67(3), 1672-1675.
[http://dx.doi.org/10.1128/jvi.67.3.1672-1675.1993] [PMID: 8437237]
[70]
Kumar, S.; Nyodu, R.; Maurya, V.K.; Saxena, S.K. Pathogenesis and host immune response during Japanese Encephalitis virus infection. In: Innate Immunity in Health and Disease; IntechOpen, 2021.
[http://dx.doi.org/10.5772/intechopen.98947]
[71]
Chen, C.J.; Raung, S.L.; Kuo, M.D.; Wang, Y.M. Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. J. Gen. Virol., 2002, 83(8), 1897-1905.
[http://dx.doi.org/10.1099/0022-1317-83-8-1897] [PMID: 12124453]
[72]
Michaelis, M.; Kleinschmidt, M.C.; Doerr, H.W.; Cinatl, J., Jr Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J. Antimicrob. Chemother., 2007, 60(5), 981-986.
[http://dx.doi.org/10.1093/jac/dkm307] [PMID: 17872917]
[73]
Mishra, M.K.; Ghosh, D.; Duseja, R.; Basu, A. Antioxidant potential of Minocycline in Japanese Encephalitis virus infection in murine neuroblastoma cells: Correlation with membrane fluidity and cell death. Neurochem. Int., 2009, 54(7), 464-470.
[http://dx.doi.org/10.1016/j.neuint.2009.01.022] [PMID: 19428790]
[74]
Mishra, M.K.; Dutta, K.; Saheb, S.K.; Basu, A. Understanding the molecular mechanism of blood–brain barrier damage in an experimental model of Japanese encephalitis: Correlation with minocycline administration as a therapeutic agent. Neurochem. Int., 2009, 55(8), 717-723.
[http://dx.doi.org/10.1016/j.neuint.2009.07.006] [PMID: 19628016]
[75]
Banerjee, A.; Tripathi, A. Recent advances in understanding Japanese encephalitis. F1000 Res., 2019, 8, 1915.
[http://dx.doi.org/10.12688/f1000research.19693.1] [PMID: 31781366]
[76]
Dutta, K.; Ghosh, D.; Basu, A. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. J. Neuroimmune Pharmacol., 2009, 4(3), 328-337.
[http://dx.doi.org/10.1007/s11481-009-9158-2] [PMID: 19434500]
[77]
Ahmad, F.; Ahmad, S.; Husain, A.; Pandey, N.; Khubaib, M.; Sharma, R. Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: An immunotherapeutic approaches. J. Neurovirol., 2024, 30(3), 251-265.
[http://dx.doi.org/10.1007/s13365-024-01212-z] [PMID: 38842651]
[78]
Sebastian, L.; Desai, A.; Yogeeswari, P.; Sriram, D.; Madhusudana, S.N.; Ravi, V. Combination of N-methylisatin-β-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro. Lett. Appl. Microbiol., 2012, 55(3), 234-239.
[http://dx.doi.org/10.1111/j.1472-765X.2012.03282.x] [PMID: 22738253]
[79]
Sebastian, L.; Desai, A.; Madhusudana, S.N.; Ravi, V. Pentoxifylline inhibits replication of Japanese encephalitis virus: A comparative study with ribavirin. Int. J. Antimicrob. Agents, 2009, 33(2), 168-173.
[http://dx.doi.org/10.1016/j.ijantimicag.2008.07.013] [PMID: 18804347]
[80]
Takhampunya, R.; Ubol, S.; Houng, H.S.; Cameron, C.E.; Padmanabhan, R. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J. Gen. Virol., 2006, 87(7), 1947-1952.
[http://dx.doi.org/10.1099/vir.0.81655-0] [PMID: 16760396]
[81]
Schneider, W.M.; Chevillotte, M.D.; Rice, C.M. Interferon-stimulated genes: A complex web of host defenses. Annu. Rev. Immunol., 2014, 32(1), 513-545.
[http://dx.doi.org/10.1146/annurev-immunol-032713-120231] [PMID: 24555472]
[82]
Lin, C.W.; Wu, C.F.; Hsiao, N.W.; Chang, C.Y.; Li, S.W.; Wan, L.; Lin, Y.J.; Lin, W.Y. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int. J. Antimicrob. Agents, 2008, 32(4), 355-359.
[http://dx.doi.org/10.1016/j.ijantimicag.2008.04.018] [PMID: 18701259]
[83]
Yang, J.; Xu, Y.; Yan, Y.; Li, W.; Zhao, L.; Dai, Q.; Li, Y.; Li, S.; Zhong, J.; Cao, R.; Zhong, W. Small molecule inhibitor of ATPase activity of HSP70 as a broad-spectrum inhibitor against flavivirus infections. ACS Infect. Dis., 2020, 6(5), 832-843.
[http://dx.doi.org/10.1021/acsinfecdis.9b00376] [PMID: 31967789]
[84]
Anantpadma, M.; Vrati, S. siRNA-mediated suppression of Japanese encephalitis virus replication in cultured cells and mice. J. Antimicrob. Chemother., 2012, 67(2), 444-451.
[http://dx.doi.org/10.1093/jac/dkr487] [PMID: 22114132]
[85]
Shen, T.; Liu, K.; Miao, D.; Cao, R.; Chen, P. Effective inhibition of Japanese encephalitis virus replication by shRNAs targeting various viral genes in vitro and in vivo. Virology, 2014, 454-455, 48-59.
[http://dx.doi.org/10.1016/j.virol.2014.01.025] [PMID: 24725931]
[86]
Yoo, J.S.; Kim, C.M.; Kim, J.H.; Kim, J.Y.; Oh, J.W. Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting nlms on the plus- and minus-strands of viral RNA. Antiviral Res., 2009, 82(3), 122-133.
[http://dx.doi.org/10.1016/j.antiviral.2009.02.187] [PMID: 19428603]
[87]
Anantpadma, M.; Stein, D.A.; Vrati, S. Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide- conjugated morpholino oligomer. J. Antimicrob. Chemother., 2010, 65(5), 953-961.
[http://dx.doi.org/10.1093/jac/dkq074] [PMID: 20299495]
[88]
Lundin, K.E.; Good, L.; Strömberg, R.; Gräslund, A.; Smith, C.I.E. Biological activity and biotechnological aspects of peptide nucleic acid. Adv. Genet., 2006, 56, 1-51.
[http://dx.doi.org/10.1016/S0065-2660(06)56001-8] [PMID: 16735154]
[89]
Chen, J.; Yamada, S.; Hama, Y.; Shetty, A.K.; Kobayashi, T.; Oda, H.; Seiki, K.; Kim, E.; Kimura, T.; Takahashi, N.; Hidari, K.I.P.J.; Suzuki, T.; Suzuki, Y.; Sugahara, K. Unique heparan sulfate from shrimp heads exhibits a strong inhibitory effect on infections by dengue virus and Japanese encephalitis virus. Biochem. Biophys. Res. Commun., 2011, 412(1), 136-142.
[http://dx.doi.org/10.1016/j.bbrc.2011.07.059] [PMID: 21806963]
[90]
Kim, E.; Okumura, M.; Sawa, H.; Miyazaki, T.; Fujikura, D.; Yamada, S.; Sugahara, K.; Sasaki, M.; Kimura, T. Paradoxical effects of chondroitin sulfate-E on Japanese encephalitis viral infection. Biochem. Biophys. Res. Commun., 2011, 409(4), 717-722.
[http://dx.doi.org/10.1016/j.bbrc.2011.05.072] [PMID: 21621516]
[91]
Lee, E.; Pavy, M.; Young, N.; Freeman, C.; Lobigs, M. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res., 2006, 69(1), 31-38.
[http://dx.doi.org/10.1016/j.antiviral.2005.08.006] [PMID: 16309754]
[92]
Ishag, H.Z.A.; Li, C.; Huang, L.; Sun, M.; Wang, F.; Ni, B.; Malik, T.; Chen, P.; Mao, X. Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo. Arch. Virol., 2013, 158(2), 349-358.
[http://dx.doi.org/10.1007/s00705-012-1489-2] [PMID: 23053519]
[93]
Zhang, T.; Wu, Z.; Du, J.; Hu, Y.; Liu, L.; Yang, F.; Jin, Q. Anti- Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics. PLoS One, 2012, 7(1), e30259.
[http://dx.doi.org/10.1371/journal.pone.0030259] [PMID: 22276167]
[94]
Lv, B.M.; Tong, X.Y.; Quan, Y.; Liu, M.Y.; Zhang, Q.Y.; Song, Y.F.; Zhang, H.Y. Drug repurposing for Japanese Encephalitis virus infection by systems biology methods. Molecules, 2018, 23(12), 3346.
[http://dx.doi.org/10.3390/molecules23123346] [PMID: 30567313]
[95]
Wang, X.; Li, S.H.; Zhu, L.; Nian, Q.G.; Yuan, S.; Gao, Q.; Hu, Z.; Ye, Q.; Li, X.F.; Xie, D.Y.; Shaw, N.; Wang, J.; Walter, T.S.; Huiskonen, J.T.; Fry, E.E.; Qin, C.F.; Stuart, D.I.; Rao, Z. Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability. Nat. Commun., 2017, 8(1), 14.
[http://dx.doi.org/10.1038/s41467-017-00024-6] [PMID: 28446752]
[96]
Bhosale, S.; Kumar, A. Screening of phytoconstituents of Andrographis paniculata against various targets of Japanese encephalitis virus: An in-silico and in-vitro target-based approach. Curr. Res. Pharmacol. Drug Discov., 2021, 2, 100043.
[http://dx.doi.org/10.1016/j.crphar.2021.100043] [PMID: 34909671]
[97]
Bajrai, L.H.; Alandijany, T.A.; Alsaady, I.; El-Daly, M.M.; Tolah, A.M.; Khateb, A.M.; Dubey, A.; Dwivedi, V.D.; Azhar, E.I. Assessing the inhibitory potential of anti-dengue compounds against Japanese encephalitis virus RNA dependent RNA polymerase: An in silico study. J. Biomol. Struct. Dyn., 2023, 42, 11844-11860.
[http://dx.doi.org/10.1080/07391102.2023.2265489] [PMID: 37811742]
[98]
Kumar, N.; Sarma, H.; Sastry, G.N. Repurposing of approved drug molecules for viral infectious diseases: A molecular modelling approach. J. Biomol. Struct. Dyn., 2022, 40(17), 8056-8072.
[http://dx.doi.org/10.1080/07391102.2021.1905558] [PMID: 33810775]
[99]
Abate, S.K.; Garabadu, D. Virtual screening, molecular dynamics simulations, and antiviral evaluation of Ocimum basilicum Phytoconstituents Against Japanese Encephalitis Virus. Research Square, 2024.
[http://dx.doi.org/10.21203/rs.3.rs-4888640/v1]
[100]
Alhazmi, A.Y.; Khan, F.R.; Rehman, Z.; Hazazi, A.; Alotaibi, B.S.; Alharthi, N.S.; Alhuthali, H.M.; Aba Alkhayl, F.F.; Alshehri, F.F.; Alkhoshaiban, A.; Al-Otaibi, F. Structural and energetic analysis of NS5 protein inhibition by small molecules in Japanese encephalitis virus using machine learning and steered molecular dynamics approach. J. Biomol. Struct. Dyn., 2024. Epub ahead of print.
[http://dx.doi.org/10.1080/07391102.2024.2316767] [PMID: 38407246]
[101]
Hoke, C.H.; Nisalak, A.; Sangawhipa, N.; Jatanasen, S.; Laorakapongse, T.; Innis, B.L.; Kotchasenee, S.; Gingrich, J.B.; Latendresse, J.; Fukai, K.; Burke, D.S. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med., 1988, 319(10), 608-614.
[http://dx.doi.org/10.1056/NEJM198809083191004] [PMID: 2842677]
[102]
Muangchana, C.; Henprasertthae, N.; Nurach, K.; Theppang, K.; Yoocharoen, P.; Varinsathien, P.; Techathawat, S.; Sanohsieng, S.; Anantapreecha, S. Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study. Vaccine, 2012, 30(2), 361-367.
[http://dx.doi.org/10.1016/j.vaccine.2011.10.083] [PMID: 22075090]
[103]
Yu, Y. Development of Japanese Encephalitis attenuated live vaccine virus SA14-14-2 and its charcteristics. In: InTechOpen; , 2013.
[http://dx.doi.org/10.5772/52980]
[104]
Arroyo, J.; Guirakhoo, F.; Fenner, S.; Zhang, Z.X.; Monath, T.P.; Chambers, T.J. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J. Virol., 2001, 75(2), 934-942.
[http://dx.doi.org/10.1128/JVI.75.2.934-942.2001] [PMID: 11134306]
[105]
Falgout, B.; Markoff, L. Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J. Virol., 1995, 69(11), 7232-7243.
[http://dx.doi.org/10.1128/jvi.69.11.7232-7243.1995] [PMID: 7474145]
[106]
Liu, X.; Zhao, X.; Na, R.; Li, L.; Warkentin, E.; Witt, J.; Lu, X.; Yu, Y.; Wei, Y.; Peng, G.; Li, Y.; Wang, J. The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism. Protein Cell, 2019, 10(2), 149-153.
[http://dx.doi.org/10.1007/s13238-018-0551-6] [PMID: 29752689]
[107]
Luo, D.; Vasudevan, S.G.; Lescar, J. The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development. Antiviral Res., 2015, 118, 148-158.
[http://dx.doi.org/10.1016/j.antiviral.2015.03.014] [PMID: 25842996]
[108]
Gorbalenya, A.E.; Donchenko, A.P.; Koonin, E.V.; Blinov, V.M. N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res., 1989, 17(10), 3889-3897.
[http://dx.doi.org/10.1093/nar/17.10.3889] [PMID: 2543956]
[109]
Zhu, Y.; Chen, S.; Lurong, Q.; Qi, Z. Recent advances in antivirals for Japanese Encephalitis Virus. Viruses, 2023, 15(5), 1033.
[http://dx.doi.org/10.3390/v15051033] [PMID: 37243122]
[110]
Lescar, J.; Luo, D.; Xu, T.; Sampath, A.; Lim, S.; Canard, B.; Vasudevan, S. Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res., 2008, 80(2), 94-101.
[http://dx.doi.org/10.1016/j.antiviral.2008.07.001] [PMID: 18674567]
[111]
Yin, C.; Yang, P.; Xiao, Q.; Sun, P.; Zhang, X.; Zhao, J.; Hu, X.; Shan, C. Novel antiviral discoveries for Japanese encephalitis virus infections through reporter virus-based high-throughput screening. J. Med. Virol., 2024, 96(1), e29382.
[http://dx.doi.org/10.1002/jmv.29382] [PMID: 38235833]
[112]
Wang, P.; Li, M.; Lu, W.; Zhang, D.; Hu, Q.; Liu, Y. DC-SIGN promotes Japanese encephalitis virus transmission from dendritic cells to T cells via virological synapses. Virol. Sin., 2017, 32(6), 495-502.
[http://dx.doi.org/10.1007/s12250-017-4034-3] [PMID: 28865053]
[113]
Miner, J.J.; Daniels, B.P.; Shrestha, B.; Proenca-Modena, J.L.; Lew, E.D.; Lazear, H.M.; Gorman, M.J.; Lemke, G.; Klein, R.S.; Diamond, M.S. The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Nat. Med., 2015, 21(12), 1464-1472.
[http://dx.doi.org/10.1038/nm.3974] [PMID: 26523970]
[114]
He, Y.; Miao, C.; Yang, S.; Xu, C.; Liu, Y.; Zhu, X.; Wen, Y.; Wu, R.; Zhao, Q.; Huang, X.; Yan, Q.; Lang, Y.; Zhao, S.; Wang, Y.; Han, X.; Cao, S.; Hu, Y.; Du, S. Sialic acids as attachment factors in mosquitoes mediating Japanese encephalitis virus infection. J. Virol., 2024, 98(5), e01959-23.
[http://dx.doi.org/10.1128/jvi.01959-23] [PMID: 38634598]
[115]
Bhaskar, M.; Satheesan, A.; Basu, A. Low-density Lipoprotein Receptor is an important host factor in flaviviral entry and replication in neurons. Biochem. Biophys. Res. Commun., 2025, 743, 151160.
[http://dx.doi.org/10.1016/j.bbrc.2024.151160] [PMID: 39689643]
[116]
Sung, P.S.; Hsieh, S.L. C-type lectins and extracellular vesicles in virus-induced NETosis. J. Biomed. Sci., 2021, 28(1), 46.
[http://dx.doi.org/10.1186/s12929-021-00741-7] [PMID: 34116654]
[117]
Chang, C.Y.; Wu, C.C.; Tzeng, C.Y.; Li, J.R.; Chen, Y.F.; Chen, W.Y.; Kuan, Y.H.; Liao, S.L.; Chen, C.J. NMDA receptor blockade attenuates Japanese encephalitis virus infection-induced microglia activation. J. Neuroinflammation, 2024, 21(1), 291.
[http://dx.doi.org/10.1186/s12974-024-03288-0] [PMID: 39511597]
[118]
Mustafá, Y.M.; Meuren, L.M.; Coelho, S.V.A.; de Arruda, L.B. Pathways exploited by flaviviruses to counteract the blood-brain barrier and invade the central nervous system. Front. Microbiol., 2019, 10, 525.
[http://dx.doi.org/10.3389/fmicb.2019.00525] [PMID: 30984122]
[119]
Yadav, P.; Chakraborty, P.; Jha, N.K.; Dewanjee, S.; Jha, A.K.; Panda, S.P.; Mishra, P.C.; Dey, A.; Jha, S.K. Molecular mechanism and role of Japanese encephalitis virus infection in central nervous system-mediated diseases. Viruses, 2022, 14(12), 2686.
[http://dx.doi.org/10.3390/v14122686] [PMID: 36560690]
[120]
Ashraf, U.; Ding, Z.; Deng, S.; Ye, J.; Cao, S.; Chen, Z. Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage. Virulence, 2021, 12(1), 968-980.
[http://dx.doi.org/10.1080/21505594.2021.1899674] [PMID: 33724154]
[121]
Alfaiz, F.A. Structural and functional analysis of Japanese encephalitis virus drug targets in focus on immune evasion mechanisms. J. King Saud Univ. Sci., 2022, 34(1), 101681.
[http://dx.doi.org/10.1016/j.jksus.2021.101681]
[122]
Hoke, C.H., Jr; Vaughn, D.W.; Nisalak, A.; Intralawan, P.; Poolsuppasit, S.; Jongsawas, V.; Titsyakorn, U.; Johnson, R.T. Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J. Infect. Dis., 1992, 165(4), 631-637.
[http://dx.doi.org/10.1093/infdis/165.4.631] [PMID: 1313068]
[123]
Kumar, R.; Basu, A.; Sinha, S.; Das, M.; Tripathi, P.; Jain, A.; Kumar, C.; Atam, V.; Khan, S.; Singh, A.S. Role of oral Minocycline in acute encephalitis syndrome in India: A randomized controlled trial. BMC Infect. Dis., 2015, 16(1), 67.
[http://dx.doi.org/10.1186/s12879-016-1385-6] [PMID: 26847071]
[124]
Kumar, R.; Tripathi, P.; Baranwal, M.; Singh, S.; Tripathi, S.; Banerjee, G. Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin. Infect. Dis., 2009, 48(4), 400-406.
[http://dx.doi.org/10.1086/596309] [PMID: 19143532]
[125]
Solomon, T.; Dung, N.M.; Wills, B.; Kneen, R.; Gainsborough, M.; Diet, T.V.; Nhu Thuy, T.T.; Loan, H.T.; Khanh, V.C.; Vaughn, D.W.; White, N.J.; Farrar, J.J. Interferon alfa-2a in Japanese encephalitis: A randomised double-blind placebo-controlled trial. Lancet, 2003, 361(9360), 821-826.
[http://dx.doi.org/10.1016/S0140-6736(03)12709-2] [PMID: 12642049]
[126]
Ayukawa, R.; Fujimoto, H.; Ayabe, M.; Shoji, H.; Matsui, R.; Iwata, Y.; Fukuda, H.; Ochi, K.; Noda, K.; Ono, Y.; Sakai, K.; Takehisa, Y.; Yasui, K. An unexpected outbreak of Japanese encephalitis in the Chugoku district of Japan, 2002. Jpn. J. Infect. Dis., 2004, 57(2), 63-66.
[PMID: 15118213]
[127]
Rayamajhi, A.; Nightingale, S.; Bhatta, N.K.; Singh, R.; Ledger, E.; Bista, K.P.; Lewthwaite, P.; Mahaseth, C.; Turtle, L.; Robinson, J.S.; Galbraith, S.E.; Wnek, M.; Johnson, B.W.; Faragher, B.; Griffiths, M.J.; Solomon, T.; Solomon, T. A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal. PLoS One, 2015, 10(4), e0122608.
[http://dx.doi.org/10.1371/journal.pone.0122608] [PMID: 25886645]
[128]
Wijesinghe, P.R.; Abeysinghe, M.R.N.; Yoksan, S.; Yao, Y.; Zhou, B.; Zhang, L.; Fleming, J.A.; Marfin, A.A.; Victor, J.C. Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine. Vaccine, 2016, 34(48), 5923-5928.
[http://dx.doi.org/10.1016/j.vaccine.2016.10.028] [PMID: 27773472]
[129]
Monath, T.P.; McCarthy, K.; Bedford, P.; Johnson, C.T.; Nichols, R.; Yoksan, S.; Marchesani, R.; Knauber, M.; Wells, K.H.; Arroyo, J.; Guirakhoo, F. Clinical proof of principle for ChimeriVax™: Recombinant live, attenuated vaccines against flavivirus infections. Vaccine, 2002, 20(7-8), 1004-1018.
[http://dx.doi.org/10.1016/S0264-410X(01)00457-1] [PMID: 11803060]
[130]
Dubischar, K.L.; Kadlecek, V.; Sablan, B.; Borja-Tabora, C.F.; Gatchalian, S.; Eder-Lingelbach, S.; Kiermayr, S.; Spruth, M.; Westritschnig, K. Immunogenicity of the inactivated Japanese Encephalitis virus vaccine IXIARO in children from a Japanese Encephalitis virus-endemic region. Pediatr. Infect. Dis. J., 2017, 36(9), 898-904.
[http://dx.doi.org/10.1097/INF.0000000000001615] [PMID: 28430748]
[131]
Yang, M.; Ding, C.; Zhao, T.; Song, G.; Liu, T.; Li, Z.; Zhang, Y. Nanoparticle-based therapies for neurotropic viral infections: Mechanisms, challenges, and future prospects. Rev. Med. Virol., 2024, 34(5), e2575.
[http://dx.doi.org/10.1002/rmv.2575] [PMID: 39160646]
[132]
Sim, T.M.; Tarini, D.; Dheen, S.T.; Bay, B.H.; Srinivasan, D.K. Nanoparticle-based technology approaches to the management of neurological disorders. Int. J. Mol. Sci., 2020, 21(17), 6070.
[http://dx.doi.org/10.3390/ijms21176070] [PMID: 32842530]
[133]
Ahsan, M.F.; Gore, M.M. Comparison of immune response generated against Japanese encephalitis virus envelope protein expressed by DNA vaccines under macrophage associated versus ubiquitous expression promoters. Virol. J., 2011, 8(1), 382.
[http://dx.doi.org/10.1186/1743-422X-8-382] [PMID: 21806845]
[134]
Sheng, Z.; Gao, N.; Cui, X.; Fan, D.; Chen, H.; Wu, N.; Wei, J.; An, J. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs. Vaccine, 2016, 34(47), 5751-5757.
[http://dx.doi.org/10.1016/j.vaccine.2016.10.001] [PMID: 27743649]
[135]
Vannice, K.S.; Hills, S.L.; Schwartz, L.M.; Barrett, A.D.; Heffelfinger, J.; Hombach, J.; Letson, G.W.; Solomon, T.; Marfin, A.A.; Anderson, K.; Fischer, M.; Fox, K.; Jacobson, J.; Liyanage, J.; Marks, F.; Ogbuanu, I.; Tharmaphornpilas, P. The future of Japanese encephalitis vaccination: Expert recommendations for achieving and maintaining optimal JE control. NPJ Vaccines, 2021, 6(1), 82.
[http://dx.doi.org/10.1038/s41541-021-00338-z] [PMID: 34131150]
[136]
Hegde, N.R.; Gore, M.M. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Hum. Vaccin. Immunother., 2017, 13(6), 1320-1337.
[http://dx.doi.org/10.1080/21645515.2017.1285472] [PMID: 28301270]

Rights & Permissions Print Cite
Article Metrics
Pdf icon 53
Html icon 1
Find your institution